Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19394096rdf:typepubmed:Citationlld:pubmed
pubmed-article:19394096lifeskim:mentionsumls-concept:C0035614lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0035950lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0679932lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0680536lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C0016674lld:lifeskim
pubmed-article:19394096lifeskim:mentionsumls-concept:C1880391lld:lifeskim
pubmed-article:19394096pubmed:issue1-2lld:pubmed
pubmed-article:19394096pubmed:dateCreated2009-5-20lld:pubmed
pubmed-article:19394096pubmed:abstractTextThis paper describes the sensitivity and specificity of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus (RVFV) from sera of French domestic ruminants. Field samples were collected from mainland France for the known-negative sera (cattle=191, goats=119, sheep=192) and from ruminants of a French overseas territory (Mayotte) for the known-positive sera. A cut-off value of 43% was determined for all species, achieving a sensitivity and specificity of 100% and a concordance of 100% with the species-specific threshold recommended by the manufacturer. Our results demonstrate that this ELISA may be a suitable diagnostic tool for disease surveillance programmes and import/export veterinary certification of French cattle, goats and sheep.lld:pubmed
pubmed-article:19394096pubmed:languageenglld:pubmed
pubmed-article:19394096pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394096pubmed:citationSubsetIMlld:pubmed
pubmed-article:19394096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19394096pubmed:statusMEDLINElld:pubmed
pubmed-article:19394096pubmed:monthJullld:pubmed
pubmed-article:19394096pubmed:issn1873-1716lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:FavreJacquesJlld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:MartinezDomin...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:LancelotRenau...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:BouloyMichèle...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:AlbinaEmmanue...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:BillecocqAgnè...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:Cêtre-SossahC...lld:pubmed
pubmed-article:19394096pubmed:authorpubmed-author:DefernezCédri...lld:pubmed
pubmed-article:19394096pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19394096pubmed:day1lld:pubmed
pubmed-article:19394096pubmed:volume90lld:pubmed
pubmed-article:19394096pubmed:ownerNLMlld:pubmed
pubmed-article:19394096pubmed:authorsCompleteYlld:pubmed
pubmed-article:19394096pubmed:pagination146-9lld:pubmed
pubmed-article:19394096pubmed:dateRevised2009-10-26lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:meshHeadingpubmed-meshheading:19394096...lld:pubmed
pubmed-article:19394096pubmed:year2009lld:pubmed
pubmed-article:19394096pubmed:articleTitleEvaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France.lld:pubmed
pubmed-article:19394096pubmed:affiliationCIRAD, UMR Contrôle des Maladies, Montpellier F-34398, France. catherine.cetre-sossah@cirad.frlld:pubmed
pubmed-article:19394096pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19394096pubmed:publicationTypeValidation Studieslld:pubmed